A detailed history of Alps Advisors Inc transactions in Mannkind Corp stock. As of the latest transaction made, Alps Advisors Inc holds 208,331 shares of MNKD stock, worth $1.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
208,331
Previous 212,437 1.93%
Holding current value
$1.27 Million
Previous $1.11 Million 18.05%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.01 - $6.7 $20,571 - $27,510
-4,106 Reduced 1.93%
208,331 $1.31 Million
Q2 2024

Aug 13, 2024

BUY
$4.05 - $5.43 $87,880 - $117,825
21,699 Added 11.38%
212,437 $1.11 Million
Q1 2024

May 14, 2024

BUY
$3.25 - $5.27 $25,213 - $40,884
7,758 Added 4.24%
190,738 $864,000
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $50,467 - $64,821
-15,110 Reduced 7.63%
182,980 $666,000
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $14,904 - $20,775
3,812 Added 1.96%
198,090 $818,000
Q2 2023

Aug 14, 2023

BUY
$3.72 - $4.79 $77,651 - $99,986
20,874 Added 12.04%
194,278 $790,000
Q1 2023

May 10, 2023

SELL
$3.95 - $5.63 $19,781 - $28,195
-5,008 Reduced 2.81%
173,404 $710,000
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $114,470 - $203,544
37,904 Added 26.98%
178,412 $940,000
Q3 2022

Nov 14, 2022

SELL
$2.99 - $4.35 $27,842 - $40,507
-9,312 Reduced 6.22%
140,508 $434,000
Q2 2022

Aug 11, 2022

SELL
$2.67 - $4.77 $290,941 - $519,772
-108,967 Reduced 42.11%
149,820 $571,000
Q1 2022

May 16, 2022

SELL
$2.62 - $4.45 $83,832 - $142,386
-31,997 Reduced 11.0%
258,787 $952,000
Q4 2021

Feb 09, 2022

BUY
$4.05 - $5.37 $1.18 Million - $1.56 Million
290,784 New
290,784 $1.27 Million
Q4 2019

Feb 07, 2020

SELL
$1.14 - $1.49 $431,055 - $563,397
-378,119 Closed
0 $0
Q3 2019

Nov 04, 2019

SELL
$1.04 - $1.44 $15,528 - $21,500
-14,931 Reduced 3.8%
378,119 $473,000
Q2 2019

Aug 07, 2019

BUY
$1.09 - $1.88 $428,424 - $738,934
393,050 New
393,050 $452,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.